Landspitali University Hospital, Iceland, Advanced Training P24

Landspitali University Hospital, Iceland, Advanced Training P24

Shaping the future of genomics at Landspítali University Hospital and the University of Iceland (Háskóli Íslands)!It was an inspiring beginning with Oxford Nanopore Technologies and the PromethION P24, as we began sequencing samples in the field of neurodevelopmental disorders — a significant step toward connecting advanced technology with impactful clinical research.A sincere thank you to the exceptional Landspítali team for the warm welcome and unwavering commitment throughout the training. Your enthusiasm and collaboration are what drive real progress.

Dr. Andreas Venizelos
Dr. Andreas Venizelos
SENIOR FIELD APPLICATIONS SCIENTIST @ OXFORD NANOPORE TECHNOLOGIES

My research interests include genomic alterations and subclonal evolution dynamics in tumours, as well as the genomic profiling of a hitherto understudied cancer type, gastroenteropancreatic neuroendocrine carcinomas (NECs).